From Bench to Bedside: Overcoming Barriers to Clinical NGS-Based Testing
Jason Myers, PhD
With simpler and more cost-effective equipment, clinics could own their sequencing and process more samples, increasing access to NGS testing
Jason Myers, PhD
Jason Myers, PhD, is the CEO of Genapsys and has more than 20 years of experience in the genomics industry. Prior to Genapsys, he was cofounder and CEO of ArcherDX, continuing his track record of successful technology development and enterprise value creation. Before that, Jason led platform and sequencing application development for Ion Torrent™, where his leadership contributed to its acquisition by Life Technologies.